MEK Inhibitor Augments Antitumor Activity of B7-H3-Redirected Bispecific Antibody.
Li H, Huang C, Zhang Z, Feng Y, Wang Z, Tang X, Zhong K, Hu Y, Guo G, Zhou L, Guo W, Xu J, Yang H, Tong A.
Li H, et al. Among authors: guo g, guo w.
Front Oncol. 2020 Aug 25;10:1527. doi: 10.3389/fonc.2020.01527. eCollection 2020.
Front Oncol. 2020.
PMID: 32984002
Free PMC article.